Published on Atlanta Dunia
A BEACON OF HOPE AND HEALING TOUCH- Dr.BINDU LINGAM
Dr. Hima Bindu Lingam is a Medical Oncologist and Hematologist who works in both patient care and clinical research at Kaiser Permanente Townpark in Kennesaw…
Published on ScienceDirect
The First Indian Mutation of NADH-Cytochrome b5 Reductase as a Cause for Type 1 Methemoglobinemia.
Congenital methemoglobinemia caused by cytochrome b5 reductase(b5R) deficiency is sporadic worldwide, although clusters of this disorder have been identified in certain ethnic groups…
Published on ASCO Publications
US Food and Drug Administration Approval Summary: Elacestrant for Estrogen Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative, ESR1-Mutated Advanced or Metastatic Breast Cancer
The US Food and Drug Administration (FDA) approved elacestrant for the treatment of postmenopausal women or adult men with estrogen receptor–positive (ER+), human epidermal growth factor receptor 2–negative (HER2–), estrogen receptor 1 (ESR1)–mutated advanced or metastatic breast cancer with disease progression after at least one line of endocrine therapy (ET)..…